Remington-Davis

Remington-Davis is a well-established, private clinical research site organization (CRO/Site) with over 30 years of experience managing more than 600 clinical trials. Its core value proposition lies in accelerating trial timelines through fast patient recruitment from a large, diverse database, rapid contract and IRB turnaround, and flexible, personalized trial management. Operating as a service provider rather than a drug developer, it mitigates sponsor risk by offering proven enrollment capabilities and high retention rates in a dedicated facility.

Integrated clinical trial site operations platform featuring a proprietary patient database (>19,000 individuals), multi-channel recruitment system (advertising, hotline, recruiters), community engagement networks, and leading-edge clinical trial data management technology for secure and accurate data collection.

Competes with other independent clinical research sites, large site networks operated by global CROs (e.g., ICON, PPD), and hospital-based academic research centers. Differentiation is based on enrollment speed, patient diversity rates, personalized service, and three decades of site management experience.